Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5599704 | Atherosclerosis | 2017 | 26 Pages |
Abstract
Baseline VITD, VITD deficiency/insufficiency and changes in VITD with statin therapy do not predict SAMS in patients with rigorously verified SAMS. However, low VITD may exacerbate statin-induced muscle injury and could contribute to SAMS development with a longer duration of statin treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Beth A. Taylor, Lindsay Lorson, C. Michael White, Paul D. Thompson,